Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapyYi Bao, Arul M. Chinnaiyan, Rahul Mannan et al.|Proceedings of the National Academy of Sciences|2023Cited by 31
Abstract 5502: Androgen blockade confers sensitivity to PIKfyve inhibition in prostate cancerYuanyuan Qiao, Arul M. Chinnaiyan, Sarah Nicole Yee et al.|Cancer Research|2023Cited by 0